SUBSCRIBE
SUBSCRIBE

Immuneering

NEWS
Business
Biotech IPO Stampede Continues with Five More Companies
The 2021 IPO stampede continues with five more companies aiming to trade on a stock exchange.
July 12, 2021
 · 
3 min read
 · 
Alex Keown
Look at these top life science startups.
Pharm Country
Top Life Science Startups to Watch in 2021
BioSpace is proud to present its NextGen Bio “Class of 2021,” a list of up-and-coming life science startups in North America that recently launched.
January 5, 2021
 · 
16 min read
 · 
Mark Terry
Pictured: A researcher working to develop new drug
Drug Development
Immuneering CEO Aims to Identify 90 Drug Programs Within Five Years
Ben Zeskind, chief executive officer of Immuneering, spoke with BioSpace following the annual J.P. Morgan Healthcare conference in San Francisco.
January 28, 2020
 · 
3 min read
 · 
Alex Keown
Load More
AWARDS
  • NextGen Class of 2021
JOBS
IN THE PRESS
Press Releases
Immuneering Appoints Andrew Gengos as Chief Financial Officer
June 15, 2026
 · 
6 min read
Press Releases
Immuneering Announces First Patient Dosed in Pivotal Phase 3 MAPKeeper 301 Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer
June 11, 2026
 · 
6 min read
Press Releases
Immuneering Presents Compelling 17.3-Month Median Overall Survival and Favorable Tolerability with Atebimetinib + Chemotherapy in First-Line Pancreatic Cancer Patients at ASCO
June 1, 2026
 · 
9 min read
Press Releases
Immuneering Reports 17.3 Months Median Overall Survival in First-Line Metastatic Pancreatic Cancer Patients Treated with Atebimetinib Plus Chemotherapy
May 22, 2026
 · 
7 min read
Press Releases
Immuneering Reports First Quarter 2026 Financial Results and Provides Business Updates
May 15, 2026
 · 
11 min read
Press Releases
Immuneering to Present New Survival Data from First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP in an Oral Presentation at the 2026 ASCO Annual Meeting
April 22, 2026
 · 
5 min read
Press Releases
Immuneering Presents Genetic Data at AACR Annual Meeting Demonstrating Mechanism to Improve Durability and Survival, Supporting Use of Atebimetinib in First-Line Pancreatic Cancer and Beyond
April 20, 2026
 · 
7 min read
Press Releases
Immuneering to Present at the 25th Annual Needham Virtual Healthcare Conference
April 7, 2026
 · 
1 min read
Press Releases
Immuneering to Present Molecular Data at 2026 AACR Annual Meeting from Atebimetinib-Treated Patients, Highlighting Mechanism Designed to Improve Durability and Survival
March 18, 2026
 · 
5 min read
Press Releases
Immuneering Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
March 6, 2026
 · 
13 min read
Load More